Aratana Therapeutics Reports Positive Pilot Field Study of AT-002 in Cats
July 27, 2015 at 07:15 AM EDT
Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of ...